A Review of Chemotherapy and Photodynamic Therapy for Lung Cancer Treatment

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..

Cancer is among the leading causes of mortality and morbidity worldwide. Among the different types of cancers, lung cancer is considered to be the leading cause of death related to cancer and the most commonly diagnosed form of such disease. Chemotherapy remains a dominant treatment modality for many types of cancers at different stages. However, in many cases, cancer cells develop drug resistance and become nonresponsive to chemotherapy, thus, necessitating the exploration of alternative and /or complementary treatment modalities. Photodynamic Therapy (PDT) has emerged as an effective treatment modality for various malignant neoplasia and tumors. In PDT, the photochemical interaction of light, Photosensitizer (PS) and molecular oxygen produces Reactive Oxygen Species (ROS), which induces cell death. Combination therapy, by using PDT and chemotherapy, can promote synergistic effect against this fatal disease with the elimination of drug resistance, and enhancement of the efficacy of cancer eradication. In this review, we give an overview of chemotherapeutic modalities, PDT, and the different types of drugs associated with each therapy. Furthermore, we also explored the combined use of chemotherapy and PDT in the course of lung cancer treatment and how this approach could be the last resort for thousands of patients that have been diagnosed by this fatal disease.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

Anti-cancer agents in medicinal chemistry - 21(2021), 2 vom: 01., Seite 149-161

Sprache:

Englisch

Beteiligte Personen:

El-Hussein, Ahmed [VerfasserIn]
Manoto, Sello L [VerfasserIn]
Ombinda-Lemboumba, Saturnin [VerfasserIn]
Alrowaili, Ziyad A [VerfasserIn]
Mthunzi-Kufa, Patience [VerfasserIn]

Links:

Volltext

Themen:

Antineoplastic Agents
Cancer
Chemotherapeutic agents
Chemotherapy
Journal Article
Lung cancer
Nanomaterial
Photodynamic therapy
Photosensitizer
Photosensitizing Agents
Reactive Oxygen Species
Review

Anmerkungen:

Date Completed 23.06.2021

Date Revised 08.02.2022

published: Print

Citation Status MEDLINE

doi:

10.2174/1871520620666200403144945

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM308282353